Specific resistance to VEGFR inhibitors arises from the up-regulation of fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF), with off-target effects manifesting as hypertension, proteinuria, and gastrointestinal toxicity [59]. Here, KDR is linked to hypertensive disorder.